Eversheds advises Recordati Spa on the acquisition of shares in Opalia Pharma
Eversheds has advised Recordati Spa, an Italian group of pharmaceutical laboratories, on the acquisition of 67 per cent of shares in Tunisian pharmaceutical company Opalia Pharma.
Milan-based Recordati was advised by Eversheds Paris in collaboration with Eversheds El Heni in Tunisia, with partners Boris Martor, Farès Koussay El Heni, Raouf Mohamed El Heni and Dan Roskis working closely with associates Jawad Fassi-Fehri and Imène Boukadoum.
Further counsel was provided by Anna Buscall of Arnold & Porter.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
Jackson LJ approved an amendment to CPR 3.8 (following on from the case of Hallam) to allow parties to agree a short time extension of up to 28 days.
The claimant in Rainford v Lawrenson was walking with her sister from her home to a bus stop on the A588 to catch a bus to school when she was knocked over by a car.
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe